CEA Test Kit

Introduction CEA Test Kit

The CEA test kit is designed for the quantitative measurement of Carcinoembryonic Antigen in human serum or plasma. CEA is a tumor marker that can be used to monitor selected patients with cancer, assess changes during treatment, and support the evaluation of possible disease recurrence alongside other clinical findings.

The CEA test kit is designed for the quantitative measurement of Carcinoembryonic Antigen in human serum or plasma. CEA is a tumor marker that can be used to monitor selected patients with cancer, assess changes during treatment, and support the evaluation of possible disease recurrence alongside other clinical findings.

The kit is described as using a chemiluminescence immunoassay (CLIA) method and is specified for use with the CLIA PV 1800 analyzer. It is supplied in a 100-test pack. Results should be interpreted in the context of the patient's condition, cancer type, and other diagnostic findings.

Clinical Applications of the CEA Test Kit

• Monitoring changes in CEA levels in selected patients with cancer

• Supporting treatment-response assessment alongside clinical examination and other investigations

• Contributing to the evaluation of possible disease recurrence during follow-up

• Providing additional information in the assessment of selected malignancies, including colorectal cancer

• Use in laboratory investigations related to lung, breast, and certain other cancers, depending on the clinical context

Elevated CEA levels may be associated with certain cancers, but they can also occur in non-malignant conditions. CEA testing alone is therefore not suitable for general cancer screening or definitive cancer diagnosis. Results must be interpreted within the broader clinical context.

General Product Specifications

Features and Operational Benefits

Quantitative Carcinoembryonic Antigen Measurement

Quantitative CEA testing determines the concentration of this marker in a patient sample. When measured using an appropriate laboratory method and interpreted correctly, changes over time may help support disease monitoring and treatment-response assessment.

Use in Patient Follow-Up

CEA has clinical utility in selected settings, particularly in the follow-up of patients with colorectal cancer. Its use should be aligned with the cancer type, treatment plan, and relevant clinical guidelines and should not replace other assessment methods.

Compatibility with the CLIA PV 1800 Analyzer

The provided product information specifies compatibility with the CLIA PV 1800 analyzer. Confirm the exact product identification and operating requirements against the manufacturer's official instructions before use.

100-Test Pack

The 100-test pack can help laboratories plan reagent use and manage inventory for routine CEA testing. The number of reportable patient tests may vary depending on calibration, quality-control, and other laboratory requirements.

Important Considerations When Interpreting CEA Results

• CEA does not diagnose cancer on its own: Elevated levels may occur in non-malignant conditions as well as in cancer.

• Monitoring and screening are different uses: CEA is primarily used to follow selected patients and assess disease trends; it is not recommended for general population cancer screening.

• Serial measurements can be informative: Comparing results over time may provide more context than a single measurement.

• Clinical context matters: Cancer type, treatment history, patient status, and other diagnostic findings affect interpretation.

What to Check Before Buying a CEA Test Kit

Before selecting a kit for laboratory use, review the following:

• Analyzer compatibility: Confirm compatibility with the CLIA PV 1800 and its operating requirements.

• Analytical performance: Review the measuring range, sensitivity, precision, and reproducibility in the official documentation.

• Sample requirements: Confirm the accepted serum and plasma types.

• Storage conditions: Follow the manufacturer's instructions for storage temperature, expiry date, and reagent stability.

• Quality control: Perform calibration and quality-control procedures according to the product instructions and laboratory protocols.

• Pack details: Verify the test count and package contents before ordering.

Frequently Asked Questions About the CEA Test Kit

What does the CEA test measure?

It quantitatively measures Carcinoembryonic Antigen in serum or plasma. CEA is used in monitoring selected patients with cancer.

Can CEA testing definitively diagnose cancer?

No. CEA levels may be elevated in both malignant and non-malignant conditions. Cancer diagnosis requires assessment of the broader clinical and diagnostic picture.

Can CEA be used to monitor treatment?

Yes. In selected cancers, changes in CEA may support assessment of disease trends and treatment response when interpreted alongside other findings. Its usefulness depends on the cancer type and the patient's circumstances.

Which analyzer is this kit compatible with?

The provided product information specifies compatibility with the CLIA PV 1800 analyzer. Confirm the detailed technical requirements in the manufacturer's documentation.

How many tests are included?

The product is specified as a 100-test pack. The number of reportable patient tests may depend on calibration and quality-control requirements.

Buying the 100-Test CEA Kit

Before purchasing the CEA test kit for the CLIA PV 1800 analyzer, review its technical specifications, storage requirements, expiry date, and compatibility with your laboratory equipment. Contact the sales team for current pricing, ordering details, and delivery information.

Technical Specifications CEA Test Kit

User comments